African drugmakers develop local treatments for sickle cell disease

African drugmakers and health researchers are linking local pharmaceutical production to the fight against sickle cell disease. Locally developed treatments are emerging in Senegal and Nigeria, addressing a disease that disproportionately affects the continent. The WHO strongly recommends hydroxyurea for children and adolescents with sickle cell disease, emphasizing the importance of accessibility and child-friendly formulations.